Target intelligence / Profile preview

Class A beta-lactamase enzyme; Class C beta-lactamase enzyme (None standard; commonly used abbreviations include TEM, SHV, CTX-M for Class A, and AmpC for Class C, but these refer to specific enzyme families or types rather than the whole class[5][7][8].)

Target
None standard; commonly used abbreviations include TEM, SHV, CTX-M for Class A, and AmpC for Class C, but these refer to specific enzyme families or types rather than the whole class[5][7][8].
Molecular classification
Enzyme, Hydrolase (EC 3.5.2.6), Serine hydrolase (specifically for Class A and C), Beta-lactamase
01

Overview

Class A and class C beta-lactamase enzymes are serine-active enzymes produced by bacteria that confer resistance to beta-lactam antibiotics (such as penicillins and cephalosporins) by hydrolyzing the amide bond of the beta-lactam ring[1][8]. Class A beta-lactamases include many major broad-spectrum enzymes (such as TEM, SHV, CTX-M), using a conserved serine in the active site, and are often plasmid-encoded, facilitating horizontal gene transfer[3][4][6]. Class C beta-lactamases (cephalosporinases or AmpC enzymes) are typically chromosomally encoded and confer resistance primarily to cephalosporins, but also to penicillins, and are notable for their resistance to many beta-lactamase inhibitors[5][9]. Both play major roles in clinical antibiotic resistance and are key drug targets for the development of new beta-lactamase inhibitors[4][5][8]. **Note:** For structured data purposes, Class A beta-lactamase enzyme and Class C beta-lactamase enzyme **should be listed separately** due to clear biochemical, phylogenetic, and clinical distinctions[1][5][6][9].

Other names
Beta-lactamase Class ABeta-lactamase Class CSerine beta-lactamase (applies to both A and C, as both use a serine in the active site)Cephalosporinase (commonly for Class C/AmpC)Extended-spectrum beta-lactamase (may apply to certain class A)AmpC beta-lactamase (Class C)TEM, SHV, CTX-M (examples from Class A)Various enzyme family names: ACT, ACC, ADC, CMH, CMY, FOX, MOX, PDC, TRU (mostly Class C)[5][9]
02

Mechanism of action

Hydrolysis of the beta-lactam ring in antibiotics, rendering them inactive[8] Acyl-enzyme intermediate (serine acts as nucleophile in both classes) Resistance mechanism against beta-lactam drugs

03

Biological functions

Antibiotic resistance (hydrolyzes beta-lactam antibiotics)Cell wall protection in bacteria (by inactivating antibiotics that target cell wall synthesis)[8]Substrate hydrolysis (beta-lactam ring cleavage)
04

Disease associations

Infection (primary role in bacterial resistance to antibiotics, particularly in clinical and hospital-acquired infections)[8]Other (role in the spread of multidrug-resistant pathogens, complicating infection control)
05

Safety considerations

Enzyme-mediated antibiotic resistance causes failure of antibiotic therapy[8]Rapid evolution and spread of beta-lactamase genes among pathogens[4][5]Diagnostic challenge in detecting all beta-lactamase producersLimited treatment options for infections by bacteria carrying class A and/or class C beta-lactamases
06

Interacting drugs

Beta-lactam antibiotics (e.g., penicillins, cephalosporins, monobactams, carbapenems)

1 more in the full profile.

07

Biomarkers

Presence of class A or class C beta-lactamase genes (e.g., bla_TEM, bla_SHV, bla_CTX-M for Class A; bla_AmpC/ampC for Class C)[5]Expression of specific family genes (e.g., detection by PCR or immunoassay)

Beyond the preview

Go deeper on Class A beta-lactamase enzyme; Class C beta-lactamase enzyme (None standard; commonly used abbreviations include TEM, SHV, CTX-M for Class A, and AmpC for Class C, but these refer to specific enzyme families or types rather than the whole class[5][7][8].).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Class A beta-lactamase enzyme; Class C beta-lactamase enzyme (None standard; commonly used abbreviations include TEM, SHV, CTX-M for Class A, and AmpC for Class C, but these refer to specific enzyme families or types rather than the whole class[5][7][8].).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call